Trial Profile
An Open-Label, Multicenter Study of Patient-Reported Satisfaction Following Twice Daily Dosing With Betamethasone Dipropionate Spray, 0.05% in Subjects With Moderate Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2024
Price :
$35
*
At a glance
- Drugs Betamethasone dipropionate (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Primus Pharmaceuticals; Promius Pharma
- 18 Nov 2016 Status changed from active, no longer recruiting to completed.
- 07 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2016.
- 07 Jul 2016 Status changed from recruiting to active, no longer recruiting.